-
公开(公告)号：US11413318B2
公开(公告)日：2022-08-16
申请号：US16903989
申请日：2020-06-17
IPC分类号： A61K35/742 , A61P1/00 , A61K31/352
摘要： The present invention discloses a method for therapeutic management of atrophic gastritis and colitis using a composition comprising Bacillus coagulans MTCC 5856 individually or in combination with anthocyanins. The invention further discloses a method for preventing neoplastic transformation of mucosal cells in gastro-intestinal tract and improving gut barrier function in mammals using a composition comprising Bacillus coagulans MTCC 5856 individually or in combination with anthocyanins.
-
公开(公告)号：US11419906B2
公开(公告)日：2022-08-23
申请号：US16836066
申请日：2020-03-31
申请人： Muhammed Majeed , Kalyanam Nagabhushanam , Kirankumar Beede , Sivakumar Arumugam , Shaheen Majeed
发明人： Muhammed Majeed , Kalyanam Nagabhushanam , Kirankumar Beede , Sivakumar Arumugam , Shaheen Majeed
IPC分类号： A61K35/742 , A61K38/46 , A61K38/47
摘要： The present invention discloses the potential of probiotic bacteria Bacillus coagulans individually or in combination with multi-enzyme complex for reducing gluten content in foods rich in gluten and for the increased utilization of gluten. The invention further discloses a method for the management of gluten intolerance using composition comprising Bacillus coagulans and multi-enzyme complex in mammals.
-
公开(公告)号：US11202810B2
公开(公告)日：2021-12-21
申请号：US16372635
申请日：2019-04-02
IPC分类号： A61K35/742 , A61P1/00 , A61K38/43 , A61K9/48 , A61K9/00
摘要： The present invention discloses a stable probiotic composition comprising Bacillus coagulans individually and/or in combination with multi-enzyme complex for the utilization of lactose and therapeutic management of lactose intolerance. It also discloses a method for the management of lactose intolerance using composition comprising Bacillus coagulans individually and/or in combination with multi-enzyme complex.
-
公开(公告)号：US20200338139A1
公开(公告)日：2020-10-29
申请号：US16765372
申请日：2018-12-04
IPC分类号： A61K35/742 , A61K36/45 , A61K9/00
摘要： The present invention discloses the microbial anti-adhesion effect of probiotic bacteria Bacillus coagulans MTCC 5856. More specifically the invention discloses the ability of a composition containing probiotic bacteria Bacillus coagulans MTCC 5856 in inhibiting the adhesion of harmful pathogenic microbes to the skin and mucosal surfaces thereby preventing the occurrence of an infection. Compositions containing probiotic bacteria Bacillus coagulans MTCC 5856 along with plant/fruit extracts for use as an anti-adhesion agent are also disclosed.
-
公开(公告)号：US20200316140A1
公开(公告)日：2020-10-08
申请号：US16836066
申请日：2020-03-31
申请人： Muhammed Majeed , Kalyanam Nagabhushanam , Kirankumar Beede , Sivakumar Arumugam , Shaheen Majeed
发明人： Muhammed Majeed , Kalyanam Nagabhushanam , Kirankumar Beede , Sivakumar Arumugam , Shaheen Majeed
IPC分类号： A61K35/742 , A61K38/46 , A61K38/47
摘要： The present invention discloses the potential of probiotic bacteria Bacillus coagulans individually or in combination with multi-enzyme complex for reducing gluten content in foods rich in gluten and for the increased utilization of gluten. The invention further discloses a method for the management of gluten intolerance using composition comprising Bacillus coagulans and multi-enzyme complex in mammals.
-
公开(公告)号：US20200316139A1
公开(公告)日：2020-10-08
申请号：US16372635
申请日：2019-04-02
IPC分类号： A61K35/742 , A61P1/00 , A61K9/00 , A61K9/48 , A61K38/43
摘要： The present invention discloses a stable probiotic composition comprising Bacillus coagulans individually and/or in combination with multi-enzyme complex for the utilization of lactose and therapeutic management of lactose intolerance. It also discloses a method for the management of lactose intolerance using composition comprising Bacillus coagulans individually and/or in combination with multi-enzyme complex.
-
公开(公告)号：US20190290671A1
公开(公告)日：2019-09-26
申请号：US16361457
申请日：2019-03-22
IPC分类号： A61K31/7034 , A61P3/06 , A61K31/05
摘要： Disclosed are the hypolipidemic effects of a composition comprising at least 10% w/w or above of 1-O-galloyl-β-D-glucose (β-glucogallin). The composition is effective in reducing the circulating levels of total cholesterol, triglycerides, LDL, cholesterol:HDL ratio and increasing HDL levels. The invention also discloses a method for reducing absorption and bio-accessibility of lipids in mammals using the abovementioned composition.
-
公开(公告)号：US20190085277A1
公开(公告)日：2019-03-21
申请号：US16136475
申请日：2018-09-20
申请人： Muhammed Majeed , Kalyanam Nagabhushanam , Sivakumar Arumugam , Furqan Ali , Shaheen Majeed , Kirankumar Beede
发明人： Muhammed Majeed , Kalyanam Nagabhushanam , Sivakumar Arumugam , Furqan Ali , Shaheen Majeed , Kirankumar Beede
IPC分类号： C12C12/00 , A23L33/135 , A61K35/742 , A61K9/00
摘要： A probiotic-alcoholic beverage composition comprising Bacillus coagulans is disclosed herein wherein the said spore or vegetative cell of Bacillus coagulans exhibited high recovery, tolerability, compatibility and viability of spores and vegetative cells after brewing. Methods for brewing an alcoholic beverage composition comprising Bacillus coagulans wherein said spore or bacterium is added during pre-fermentation, during fermentation and post fermentation stages are also disclosed.
-
公开(公告)号：US20180344627A1
公开(公告)日：2018-12-06
申请号：US15996725
申请日：2018-06-04
申请人： Muhammed Majeed , Kalyanam Nagabhushanam , Sivakumar Arumugam , Furqan Ali , Shaheen Majeed , Lakshmi Mundkur
发明人： Muhammed Majeed , Kalyanam Nagabhushanam , Sivakumar Arumugam , Furqan Ali , Shaheen Majeed , Lakshmi Mundkur
摘要： Disclosed are the skin care applications of a composition containing the partially purified extracellular metabolite isolated from Bacillus coagulans MTCC 5856. More specifically, the invention discloses the ability of the partially purified extracellular metabolite isolated from Bacillus coagulans MTCC 5856 to confer protection to the skin fibroblasts against UV induced cell damage and apoptosis, oxidative stress and inflammation.
-
公开(公告)号：US20180117127A1
公开(公告)日：2018-05-03
申请号：US15342140
申请日：2016-11-03
CPC分类号： A61K38/4886 , A61K38/465 , A61K38/47 , C12Y302/01001 , C12Y302/01004 , C12Y302/01108 , C12Y304/24004
摘要： The present invention discloses a combination of digestive enzymes (Protease, Amylase, Lactase, Lipase, Cellulase)—DigeZyme® for the therapeutic management of delayed onset muscle soreness (DOMS)
-
-
-
-
-
-
-
-
-
搜索结果
32 条记录 (耗时 0.039 秒)
